Table 2.
Baseline levels of cardiometabolic markers according to serum 25(OH)D concentrations among participants with OA
| Serum 25(OH)D concentrations (nmol/L) | P-value | ||||
|---|---|---|---|---|---|
| < 25.00 | 25.00–49.99 | 50.00–74.99 | ≥ 75.00 | ||
| Glycohemoglobin (%) | 6.11 ± 1.00 | 6.01 ± 1.17 | 5.81 ± 0.88 | 5.76 ± 0.72 | <0.01 |
| Glucose, refrigerated serum (mg/dL) | 107.38 ± 37.24 | 111.62 ± 48.65 | 103.66 ± 33.25 | 102.25 ± 28.10 | <0.01 |
| Cholesterol (mg/dL) | 199.24 ± 39.41 | 201.03 ± 45.62 | 199.61 ± 42.95 | 201.46 ± 42.75 | 0.76 |
| Direct HDL-cholesterol (mg/dL) | 54.96 ± 14.38 | 53.02 ± 16.13 | 53.15 ± 15.54 | 57.15 ± 16.90 | <0.01 |
| LDL-cholesterol (mg/dL) | 111.00 ± 32.59 | 117.08 ± 37.38 | 116.48 ± 36.58 | 114.50 ± 36.59 | 0.48 |
| Triglycerides (mg/dL) | 153.18 ± 98.98 | 159.22 ± 117.47 | 159.46 ± 110.97 | 159.37 ± 108.93 | 0.81 |
| eGFR (mL/min/1.73 m2) | 81.14 ± 27.80 | 80.81 ± 25.29 | 77.11 ± 20.91 | 73.37 ± 20.86 | <0.01 |
| Uric acid (mg/dL) | 6.15 ± 1.70 | 5.64 ± 1.45 | 5.58 ± 1.47 | 5.48 ± 1.45 | <0.01 |
| C-reactive protein (mg/dL) | 0.84 ± 1.39 | 0.55 ± 0.66 | 0.50 ± 0.80 | 0.49 ± 0.96 | <0.01 |
Mean ± SD for continuous variables: P-value was calculated by weighted linear regression model